Total medical devices industry M&A deals worth $26.81bn were announced in North America in Q1 2021, led by OptumInsight’s $13bn acquisition of Change Healthcare, according to GlobalData’s deals database.
- Embed this chart
Embed this chart into your website
Copy and paste the image source into your website to display the chart.
The value marked an increase of 124.5% over the previous quarter and a rise of 70.9% when compared with the last four-quarter average of $15.69bn.
North America held an 87.33% share of the global medical devices industry M&A deal value that totalled $30.7bn in Q1 2021. With an 86.74% share and deals worth $26.63bn, the US was the top country in North America’s M&A deal value across medical devices industry.
In terms of deal activity, North America recorded 94 deals during Q1 2021, marking an increase of 30.56% over the previous quarter and a rise of 47.45% over the last four-quarter average. The US recorded 85 deals during the quarter.
North America medical devices industry M&A deals in Q1 2021: Top deals
The top five medical devices industry M&A deals accounted for 76.2% of the overall value during Q1 2021.
The combined value of the top five M&A deals stood at $20.42bn, against the overall value of $26.81bn recorded for the quarter.
The top five medical devices industry deals of Q1 2021 tracked by GlobalData were:
1) OptumInsight’s $13bn acquisition of Change Healthcare
2) The $4.6bn acquisition of Cantel Medical by Steris
3) Boston Scientific’s $1.23bn acquisition of 78% stake in Preventice
4) The $800m acquisition of Surgical Specialties by Corza Health
5) The merger of CM Life Sciences and Mount Sinai Genomics for $793m.